Plasma metabolomics and clinical predictors of survival differences in COPD patients

Plasma metabolomics and clinical predictors of survival differences in COPD patients

Abstract Background Plasma metabolomics profile (PMP) in COPD has been associated with clinical characteristics, but PMP’s relationship to survival has not been reported. We determined PMP differences between patients with COPD who died an average of 2 years after enrollment (Non-survivors, NS) comp...

Full description

Bibliographic Details
Main Authors: Victor Pinto-Plata, Ciro Casanova, Miguel Divo, Yohannes Tesfaigzi, Vince Calhoun, Jing Sui, Francesca Polverino, Carmen Priolo, Hans Petersen, Juan Pablo de Torres, Jose Maria Marin, Caroline A. Owen, Rebeca Baz, Elizabeth Cordova, Bartolome Celli
Format: Article
Language:English
Published: BMC 2019-10-01
Series:Respiratory Research
Subjects:
COPD
Metabolomics
Survival
Dyspnea
Exercise capacity
Online Access:http://link.springer.com/article/10.1186/s12931-019-1167-y

Internet

http://link.springer.com/article/10.1186/s12931-019-1167-y

Similar Items